Literature DB >> 19100429

Liver failure and the need for transplantation in three patients with hepatoportal sclerosis.

B Geramizadeh1, S A Malek-Hosseini, H Salahi, A Bahador, S Nikeghbalian.   

Abstract

Hepatoportal sclerosis (HPS) is one of the causes of noncirrhotic portal hypertension. In most patients, hepatic synthetic dysfunction does not occur; rarely they may require liver transplantation. In this study, we have reported the clinicopathologic characteristics of 3 patients diagnosed with HPS after examination of the explanted liver. Small liver volume, significant portal fibrosis, and phlebosclerosis may contribute to hepatic synthetic dysfunction in patients with HPS.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19100429     DOI： 10.1016/j.transproceed.2008.06.104

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


  4 in total

1.  The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.

Authors:  Thomas D Schiano; Alison Uriel; Douglas T Dieterich; M Isabel Fiel
Journal:  Virchows Arch       Date:  2010-11-06       Impact factor: 4.064

2.  Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients.

Authors:  Sanjiv Saigal; Nabeen C Nayak; Deepali Jain; Vinay Kumaran; Ravi Mohanka; Neeraj Saraf; Amit Rastogi; Naimesh Mehta; Samiran Nundy; Arvinder Soin
Journal:  Hepatol Int       Date:  2011-01-12       Impact factor: 6.047

Review 3.  Role of Histopathologist in Liver Transplantation.

Authors:  B Geramizadeh; S A Malek-Hosseini
Journal:  Int J Organ Transplant Med       Date:  2017-02-01

4.  Hepatoportal sclerosis in childhood: descriptive analysis of 12 patients.

Authors:  Mustafa Serdar Cantez; Nelgin Gerenli; Vildan Ertekin; Mine Güllüoğlu; Özlem Durmaz
Journal:  J Korean Med Sci       Date:  2013-09-25       Impact factor: 2.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.